FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076934 [Registered on: 18/11/2024] Trial Registered Prospectively
Last Modified On: 02/05/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective observational 
Study Design  Other 
Public Title of Study   A study to validate BTL-001-2 ABPM Blood Pressure instrument.  
Scientific Title of Study   A Clinical Study to Validate BTL-001-2 ABPM (Ambulatory Non-Invasive Blood Pressure Sphygmomanometer) according to the British Hypertension Society Protocol. 
Trial Acronym  NA 
Secondary IDs if Any  
Secondary ID  Identifier 
21PR0185-008  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Meghana Murthy 
Designation  Consultant Physician 
Affiliation  Vagus Super Specialty Hospital 
Address  Vagus Super Specialty Hospital Pvt Ltd No 67 8 18th Cross 4th main Malleswaram Bengaluru

Bangalore
KARNATAKA
560055
India 
Phone  8151994080  
Fax    
Email  meggydoc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Arabinda Patnaik 
Designation  Associate Director, Project Operations 
Affiliation  Syncorp Health Pvt. Ltd.  
Address  No 6 3rd Floor second Main Road sarvobhaogam Nagar Arekere Bangalore

Bangalore
KARNATAKA
560076
India 
Phone  9014308214  
Fax    
Email  arvind.p@syncorphealth.com  
 
Details of Contact Person
Public Query
 
Name  Arabinda Patnaik 
Designation  Associate Director, Project Operations 
Affiliation  Syncorp Health Pvt. Ltd.  
Address  No 6 3rd Floor second Main Road sarvobhaogam Nagar Arekere Bangalore

Bangalore
KARNATAKA
560076
India 
Phone  9014308214  
Fax    
Email  arvind.p@syncorphealth.com  
 
Source of Monetary or Material Support  
Vagus Super Specialty Hospital Pvt Ltd No 67 8 18th Cross 4th main Malleswaram Bengaluru Karnataka India 560055 
 
Primary Sponsor  
Name  BTL India Pvt Ltd 
Address  7th Floor, Tower 1, Umiya Business Bay, Embassy Tech Square Main Rd, Kaverappa Layout, Kadubeesanahalli, Kadubeesanahalli, Bengaluru, Karnataka 560103  
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Meghana Murthy  Vagus Super Specialty Hospital  Room no-03 Ground Floor Department of general medicine No 67 8 18th Cross 4th main Malleswaram Bengaluru Karnataka India 560055
Bangalore
KARNATAKA 
08151994080

meggydoc@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Durgamba Independent Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Blood Pressure Monitoring 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  BPMR-111 Regular Blood Pressure monitor manufactured by Diamond®  BPMR-111 Regular Blood Pressure monitor manufactured by Diamond® 
Intervention  BTL-001-2 ABPM  Ambulatory Non-Invasive Blood Pressure Sphygmomanometer 
 
Inclusion Criteria
Modification(s)  
Age From  15.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Subjects should be at least 15 years of age.
2. Arm circumference between 14 cm - 50 cm.
3. Willing to participate must be able to provide an informed consent or have legally
authorized representative consent to participate.
4. Subjects that can tolerate a waiting period for up to 1 hour.
 
 
ExclusionCriteria 
Details  1.Arm circumference is less than 14 cm or greater than 50 cm.
2. Irregular heart rhythm (bigeminy, trigeminy, isolated ventricular premature beat (VPB),atrial fibrillation)
3. Korotkoffs sound K1 or K5 not audible.
4. Musculoskeletal disorder that prevents a non-invasive device to be inflated/deflated on the arm.
5. Unwilling to volunteer to participate and to sign the study specific informed consent form.
6. Patients suffering with Parkinson’s disease or other diseases with tremors.
7. Patients with coagulation disturbances.
8. Patients with serious mobility or other impairments without supervision.
9. Patients requiring urgency/emergency cardiac care
10. History of bleeding disorder and intake of anticoagulant medication
11. Persistence of Korotkoff sounds until near zero pressure 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary objective of this study is to clinically validate non-invasive
blood pressure measurement accuracy of the BTL-001-2 ABPM non invasive blood pressure monitoring device to the British Hypertension
Society protocol requirements. 
1st reading
2nd reading
3rd reading
4th reading
5th reading
6th reading
7th reading 
 
Secondary Outcome  
Outcome  TimePoints 
Documenting adverse events (AEs) serious adverse events (SAEs),
and device deficiencies 
1st reading
2nd reading
3rd reading
4th reading
5th reading
6th reading
7th reading 
 
Target Sample Size   Total Sample Size="114"
Sample Size from India="114" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   19/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The purpose of the protocol is to offer evidence of accuracy for the BTL-001-2 Ambulatory blood pressure monitoring device for the intended use in the adult population as per BHS protocol. The same arm sequential method with dual observer auscultation will be used to collect data. The procedure, data collection and data analysis methods that are followed in this protocol are as per The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. The aim is to provide accurate data of non-invasive blood pressure (NIBP) to support validation of the BTL-001-2 ambulatory blood pressure monitoring device. The anticipated benefits of this study sought to outweigh the possible risk associated with the device. There are no known contraindications, other than those noted in study’s exclusion criteria, for use in the proposed clinical study or study population.  
Close